Inhibiting TROP2 in advanced non-small-cell lung cancer with sacituzumab govitecan, datopotamab deruxtecan, and sacituzumab tirumotecan: similarities and differences

By Yangqingqing Zhou, Wunan Huang, Xinyue Hang, Yanlin He, Ruiyuan He, Chaosheng Gan. 2025